Inari Medical, Inc. announced that Chief Operating Officer Drew Hykes will succeed Bill Hoffman as Chief Executive Officer, effective January 1, 2023. Mr. Hykes joined Inari in 2017 as Chief Commercial Officer and has served as the Company's Chief Operating Officer since 2020. Prior to Inari, he served in various leadership roles at both public and private medical device companies.

A proven operating executive with broad functional, geographic and sector experience, he has leveraged decades of experience in the medical device space to advance the Company's mission of effectively treating venous thromboembolism and transforming the lives of patients suffering from venous diseases. Mr. Hykes is a proven medical device operating executive with broad functional, geographic and sector experience. Since 2020, he has served as Chief Operating Officer of Inari Medical leading its day-to-day business operations.

From 2017 to 2019, he served as Inari's Chief Commercial Officer leading the initial commercialization of Inari's solutions in the US market. From 2012 to 2016, Mr. Hykes served as the VP of Commercial Operations at Sequent Medical where he led the commercialization strategy for the WEB Aneurysm Embolization system from early prototype to broad adoption in the European market. Sequent was acquired by Terumo Corporation in July 2016 for $380 million.

Prior to Sequent, Mr. Hykes spent 11 years at Medtronic. His roles at Medtronic included the VP of Marketing for the AF Solutions business, VP of Clinical and Regulatory for the AF Solutions business and Director of Investor Relations. He also spent three years on an expatriate assignment in Europe leading the launch of Medtronic's first drug eluting coronary stent.

Prior to Medtronic, he spent four years at ABN AMRO bank in Chicago focused on healthcare transactions. Mr. Hykes holds a BBA in Finance from the University of Wisconsin and an MBA from Harvard Business School.